Excedrin Put in Review

Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.

NEW YORK Bristol-Myers Squibb has launched a review of its Excedrin creative account following Bozell’s resignation of the business, sources said.

The pharmaceutical and health-care products marketer is hearing presentations this week from New York-based roster shops Bates and Gotham for the pain-relief medication, according to sources. It is unclear if other shops are involved. The New York-based company put $25 million in measured media behind the brand for the first nine months of this year, half of what it spent for full year 2001, per CMR.

Bozell



AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in